secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001558370-24-009097
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte stockholders approve 2.3M share increase to equity incentive plan
-------------------------------------------------------------------------

- Stockholders approved amendment to 2022 Equity Incentive Plan increasing authorized shares by 2,300,000.
- Plan Amendment passed with ~58.7M votes for, ~10.8M against, ~330K abstentions.
- All three board nominees (Brooke, Johnston, Douglas) elected; CohnReznick ratified as auditor.
- Amended and Restated 2022 Plan, with details on share counting and award types, filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024009097/0001558370-24-009097-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000155837024009097/mxct-20240611x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009097

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer